🧬 Project: Genomic Feature Analysis for Cancer Classification
Objective: To apply Data Science and Machine Learning techniques to classify tumor cells as Malignant or Benign based on biological measurements.

📋 Project Pipeline
1. Data Collection & Preprocessing
Source: Breast Cancer Wisconsin (Diagnostic) Dataset.

Goal: Clean the "raw" measurements.

Key Tasks: Handling missing values, label encoding, and Feature Scaling (Standardization).

Why? Models like SVM and k-NN are sensitive to the scale of data (e.g., comparing a radius of 100mm to a texture of 0.1).

2. Exploratory Data Analysis (EDA)
Goal: Understand the "shape" of the biological data.

Techniques: Correlation Heatmaps (to find redundant genes) and Boxplots (to find outliers).

Key Concept: Multicollinearity—identifying features that are too similar.

3. Data Engineering & Balancing
Goal: Prepare data for "optimal" learning.

Techniques: Train-Test Splitting (80/20) and SMOTE (Synthetic Minority Over-sampling Technique) to handle imbalanced classes.

Importance: Ensures the model doesn't just "guess" the most common class.

4. Unsupervised Learning (Finding Hidden Patterns)
Algorithms: K-Means Clustering and Hierarchical Clustering.

Concept: Grouping patients without using labels to see if biological markers naturally form "cancer" vs "no-cancer" clusters.

Use Case: Anomaly Detection (finding rare, extreme mutations).

5. Supervised Learning (The Predictors)
Linear/Logistic Regression: Baseline probability.

k-Nearest Neighbors (k-NN): Classification by similarity.

Decision Trees & Random Forests: Tree-based logic and Ensemble learning.

Support Vector Machines (SVM): Finding the optimal hyperplane separation.

6. Model Evaluation (The "Grading" Step)
Metrics: Accuracy, Precision, Recall, and F1-Score.

Confusion Matrix: Visualizing False Positives vs. False Negatives.

Optimization: Hyperparameter testing (GridSearch) to tune the "knobs" of the models.

🔬 Scientific Context
In biological data science, we deal with High Dimensionality (many features). The challenge is distinguishing "signal" (true biological markers) from "noise" (random variation).